Navigation Links
deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
Date:10/13/2008

Latest discoveries add to understanding of individual risk of basal cell carcinoma, and are integrated into the deCODEme(TM) personal genome analysis scan

REYKJAVIK, Iceland, Oct. 13 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN) today report the discovery of common versions of two single-letter variations in the human genome (SNPs) that confer risk of basal cell carcinoma (BCC), the most common cancer among people of European ancestry. Unlike the four sets of SNPs previously found by deCODE to confer risk of BCC and cutaneous melanoma, those reported today are not linked to fair pigmentation traits that also make certain people prone to freckling and sunburn. These SNPs, both located on chromosome 1, may therefore provide new insight into an underlying biological mechanism causing BCC, independent of the impact of exposure to ultraviolet (UV) radiation in sunlight. Approximately 2% of people of European descent carry two copies of the risk versions of both SNPs, and are at a 170% greater risk of BCC than those who do not carry the risk variants. The paper, entitled 'Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigrmentation traits,' appears today in the online edition of Nature Genetics at http://www.nature.com/ng.

"With this discovery we continue to build our portfolio of novel risk factors for common skin cancers, diseases that cause significant morbidity and that are on the rise in the industrialized world. Once again we have used our capabilities in human genetics to gain a new understanding of the root causes of a major disease, that appear to act independently of known environmen
'/>"/>

SOURCE deCODE genetics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
2. Researchers decode viral process that prepares cells for HIV infection
3. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
4. deCODE genetics Announces Second Quarter 2008 Financial Results
5. deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
6. deCODE genetics to Webcast Presentations at Annual R&D Event
7. deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
8. deCODE genetics Announces First Quarter 2008 Financial Results
9. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
10. deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
11. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013  regulated information — Global ... Klauk today announced the launch of a new ... ones. The Pledge empowers the ... stand and make a personal commitment to demand more: ... health care team and additional partial-onset seizure control.  More ...
(Date:6/18/2013)... ALBANY, N.Y. , June 18, 2013 /PRNewswire/ ... that its Burlington, Mass. , ... U.S. Drug Enforcement Administration (DEA) registration to handle ... represents the DEA,s acknowledgement of Burlington,s ... inventory control and documentation. (Logo: ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished dosage ... the company has been granted a United States ... US and Europe for the oral ... 8,410,176 B2 is titled Intermediate Compounds and Processes for ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 This ... of pharmaceutical advertising and promotion, and review the ... will learn how to apply these principles through ... ,     The fundamentals on FDA regulations ... promotional labeling ,     Assessing traditional and newer ...
Breaking Biology Technology:Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2
... of Oregon physicists have successfully landed a one-two punch ... helium and then dosing its perimeter with a laser ... a near standstill. The findings, published in ... that exploits special quantum properties and in precision-measurements for ...
... Institute (PI), a leading provider of specialized training solutions for ... a new e-course titled, Introduction to Health Policy . ... Managed Markets Excellence(TM) series. The new ... of the challenges confronting the US healthcare system. ...
... Diagnostics Incorporated (NYSE: DGX ), the world,s leading ... final results for its previously announced cash tender offer to ... "Tender Cap") of its 5.125% Senior Notes due 2010 and ... terms and conditions of the tender offer are described in ...
Cached Biology Technology:Pharmaceutical Institute Launches New E-Course Focused on Health Policy 2Pharmaceutical Institute Launches New E-Course Focused on Health Policy 3Quest Diagnostics Announces Final Tender Offer Results 2Quest Diagnostics Announces Final Tender Offer Results 3
(Date:6/18/2013)... 2013 The herbal extract of a yellow-flowered mountain ... increase the lifespan of fruit fly populations by an ... , But it,s how Rhodiola rosea ... grabbed the attention of study leaders Mahtab Jafari and ... in a manner completely unrelated to dietary restriction and ...
(Date:6/18/2013)... shows that weight gain and increased head size in the first ... at early school age. , The study was led by University ... 13,800 children who were born full-term. , The results, published in ... put on 40% of their birthweight in the first four weeks ... six years of age, compared with babies who only put on ...
(Date:6/17/2013)... June 17, 2013 An international team led ... Howard Hughes Medical Institute and Albert Einstein College of ... new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium ... effort to help solve one of the major global ... its dangerous drug-resistant strains," said Peter G. Schultz, the ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2IQ link to baby's weight gain in first month 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4
... Scientists studying arsenic pollution have discovered a living sensor ... bacteria that can clean up arsenic spills even in ... September 2008) at the Society for General Microbiology,s Autumn ... The Giant Mine in Canada is in the ...
... new method to fabricate borosilicate glass nanoparticles. ... are more stable when subjected to temperature ... used nanoparticles made of polymers or silica ... of potential nanoparticle applications in biomedical, optical ...
... Society is pleased to announce the recipients of its ... awards at the Society,s 53rd Annual Meeting on Monday, ... Center in Massachusetts. The awardees are: Robert ... receive the Anatrace Membrane Protein Award for his outstanding ...
Cached Biology News:Living sensor can warn of arsenic pollution 2Biophysical Society names 2009 award recipients 2
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
adult...
DNA Purification...
Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...
Biology Products: